Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
5 NC counties are under alert, including Johnston County.
Program
After the DNC on WRAL: Shaw Universityâs president reflects on Kamala Harrisâ historic nomination. How her candidacy is inspiring her students
Program
Friday at 6 on WRAL: How much does your county spend on education? WRAL Investigates which counties are prioritizing your children.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
November 06, 2023
The company was expected to report a third-quarter loss and plummeting sales.
Via
Investor's Business Daily
This Is The 'Only Solar Stock' Jim Cramer Is Recommending 'Because It's A Pure Play'
November 06, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DocuSign, Inc.
Via
Benzinga
CPRI, SGEN, VMW: Why These 3 Stocks Are on the Tip of Bill Gross’ Tongue
November 05, 2023
Bill Gross, the Bond King, is wading into the world of equity arbitrage with these three stocks - but are they worth the risk for investors?
Via
InvestorPlace
Here's How Much You Would Have Made Owning Seagen Stock In The Last 15 Years
November 03, 2023
Via
Benzinga
Seagen Highlights First Solid Tumor Data for an ADCETRIS® (brentuximab vedotin) Immunotherapy Combination and Preclinical Data for Novel CD30-Directed Antibody-Drug Conjugate at Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 03, 2023
From
Seagen Inc.
Via
Business Wire
This High-Yield Dividend Stock Is a Proven Wealth Creator
November 02, 2023
This heavily sold-off pharma stock is a bargain.
Via
The Motley Fool
Looking At Seagen's Recent Unusual Options Activity
November 01, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
New Data for ADCETRIS® (brentuximab vedotin) with Immunotherapy Combination in Hodgkin Lymphoma to be Featured at 2023 ASH Annual Meeting, and Seagen to Unveil Novel CD30-Directed Antibody-Drug Conjugate
November 02, 2023
From
Seagen Inc.
Via
Business Wire
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress
November 01, 2023
From
Seagen Inc.
Via
Business Wire
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
October 29, 2023
Equities remain under pressure, but if you’re looking to be a contrarian investor, it’s a good time to look for undervalued long-term stocks.
Via
InvestorPlace
(SGEN) - Analyzing Seagen's Short Interest
October 23, 2023
Via
Benzinga
Seagen Inc. (NASDAQ: SGEN) Climbs to New 52-Week High
October 23, 2023
Via
Investor Brand Network
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
Earnings Outlook For Seagen
October 31, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2023
Via
Benzinga
Seagen Inc. (NASDAQ: SGEN) Sets New 52-Week High in Tuesday Session
October 24, 2023
Via
Investor Brand Network
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
October 22, 2023
The companies studied a combination of Keytruda and Padcev in bladder cancer patients.
Via
Investor's Business Daily
Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer
October 22, 2023
From
Seagen Inc.
Via
Business Wire
Here's How Much $1000 Invested In Seagen 5 Years Ago Would Be Worth Today
October 17, 2023
Via
Benzinga
How Is The Market Feeling About Seagen?
October 06, 2023
Via
Benzinga
TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial
October 22, 2023
From
Seagen Inc.
Via
Business Wire
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
The venerable pharmaceutical companies' shares have slumped this year.
Via
The Motley Fool
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
October 20, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Seagen to Highlight Overall Survival Data for PADCEV® and TIVDAK® during Presidential Symposium at ESMO Congress 2023
October 16, 2023
From
Seagen Inc.
Via
Business Wire
Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023
October 12, 2023
From
Seagen Inc.
Via
Business Wire
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment
October 11, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END
Via
FinancialNewsMedia
10 Health Care Stocks Whale Activity In Today's Session
October 09, 2023
Via
Benzinga
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
October 05, 2023
Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant...
Via
Benzinga
2 High-Yield Dividend Stocks to Buy in October
October 04, 2023
These two high-yield dividend stocks are too cheap to ignore.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.